PSA (Prostate-Specific Antigen): Meaning, Testing, and Results

A PSA test may be ordered to:

• investigate prostate-related symptoms;
• help estimate the likelihood of prostate cancer;
• monitor known prostate cancer;
• check whether cancer may have returned after treatment;
• observe changes in a prostate condition over time.

PSA is a marker, not a complete diagnosis. The result must be interpreted together with age, symptoms, medical history, examination findings, medications, and sometimes imaging or biopsy.

Common expressions include:

• PSA level;
• PSA blood test;
• elevated PSA;
• total PSA;
• free PSA;
• PSA screening;
• rising PSA.

Examples:

• His PSA level increased.
• The clinician recommended repeating the PSA test.
• A high PSA result does not always mean prostate cancer.

The expanded term prostate-specific antigen is usually treated as an uncountable noun.

Possible causes include:

• benign prostatic hyperplasia, or an enlarged prostate;
• prostatitis or prostate inflammation;
• urinary or prostate infection;
• recent ejaculation;
• vigorous cycling or similar exercise;
• recent prostate procedures or biopsy;
• increasing age;
• certain urinary problems.

Some medications used for prostate enlargement can lower measured PSA. For this reason, people should tell their clinician about medications, supplements, infections, recent procedures, and relevant activities before testing.

There is no single PSA number that can reliably separate cancer from noncancerous conditions. A lower result does not completely exclude cancer, and a higher result does not confirm it.

Clinicians may consider:

• the current PSA level;
• changes across repeated tests;
• age and prostate size;
• family and personal medical history;
• symptoms;
• examination findings;
• the proportion of free PSA;
• imaging or other biomarker results.

An unexpectedly elevated result may be repeated before more invasive testing is considered.

The current U.S. Preventive Services Task Force recommendation states that PSA screening for men aged 55–69 should be an individual decision made after discussing potential benefits and harms with a clinician. It recommends against routine PSA screening for men aged 70 or older. Other professional organizations may use different age ranges or risk-based approaches.

People at increased risk may be advised to discuss testing earlier. Risk considerations may include family history, inherited genetic variants, and ancestry.

The expected result depends on the treatment:

• after complete prostate removal, PSA usually becomes extremely low;
• after radiation therapy, some prostate tissue remains, so PSA may decline gradually rather than disappear;
• during hormone therapy or other treatment, PSA trends may help show how the cancer is responding.

A single change does not always prove recurrence. Clinicians generally examine the pattern over time and may order imaging or other tests.

Paraurethral or Skene’s gland tissue in people with typical vulvar anatomy may express PSA because this tissue has similarities to prostatic tissue. However, this does not mean that routine blood PSA testing serves the same screening role in people without a typical prostate.

PSA has also been identified in small amounts in some other tissues, so the term describes its strong association with prostate tissue rather than absolute exclusivity.

Ejaculation may temporarily increase blood PSA in some people. A healthcare service may advise avoiding ejaculation for a short period before testing, especially when a small change could influence interpretation.

Prostate disease and its treatment may also affect:

• erection;
• ejaculation;
• orgasm;
• fertility;
• urinary control;
• sexual confidence.

These effects result from the condition or treatment, not from the PSA protein itself.

A normal PSA result guarantees that no cancer is present.
Some prostate cancers occur without a markedly elevated result.

PSA is a treatment.
It is a biological marker measured through testing.

One PSA number tells the complete story.
Repeated results and other clinical information are often more useful.

“Prostate-specific” means PSA exists nowhere else.
Small amounts or PSA expression may occur in other glandular tissues.

1. PSA stands for prostate-specific antigen.
2. A PSA test measures the protein in a blood sample.
3. An enlarged prostate may raise the PSA level.
4. High PSA does not automatically mean cancer.
5. The clinician repeated the test to confirm the result.
6. PSA may be monitored after prostate-cancer treatment.
7. Recent ejaculation can temporarily affect a PSA measurement.
8. Screening decisions should consider individual risks and preferences.

Prostate conditions and cancer treatments may affect erections, ejaculation, orgasm, fertility, and urinary control. PSA testing can therefore become part of broader conversations about both cancer care and sexual well-being.

Understanding PSA helps people interpret test discussions accurately, avoid assuming that an elevated result equals cancer, and communicate more confidently about prostate health, ejaculation, treatment effects, and sexual function.